跳到正文
原文
Medical Xpress·· 2026-10-14AI 评分55

106例肾活检空间图谱揭示急性间质性肾炎的免疫细胞聚集

Kidney biopsy maps reveal immune clusters that may keep inflammation going

AI 导读

耶鲁大学团队在Nature Communications发表研究,对106例肾活检同时进行成像质谱流式与单细胞空间转录组分析,发现急性间质性肾炎(AIN)中CXCL9信号集中在淋巴细胞聚集区内。

正文
New study maps immune pathways driving acute interstitial nephritis
Multi-modal spatial profiling reveals conserved cellular architecture across imaging and transcriptomic platforms in acute kidney injury. Credit: Nature Communications (2026). DOI: 10.1038/s41467-026-77210-y

Acute interstitial nephritis (AIN) is a condition characterized by inflammation that damages the kidney's tubules and surrounding tissue. Often resulting from an immune reaction to common medications—including antibiotics, anti-inflammatory medications and drugs that treat acid reflux—the condition accounts for roughly 15% to 20% of biopsied cases of acute kidney injury (AKI), defined as a sudden decline in kidney function.

In a new study published in Nature Communications, Yale researchers used advanced cell profiling techniques to obtain the most detailed view yet of how kidney and immune cells interact in AIN.

Mapping cells without losing their location

"The standard way to measure which genes individual cells are expressing is to break the tissue apart into single cells, which destroys all of the information about how those cells were arranged and which cells were next to one another," explains the study's first author, Megan Baker, M.D., Ph.D., an instructor of medicine (nephrology) at Yale School of Medicine (YSM).

By combining technologies such as imaging mass cytometry and single-cell spatial transcriptomics, the researchers could measure gene and protein activity in individual cells while preserving each cell's location within the kidney tissue.

According to Baker, this is the first large study to map AIN at single-cell resolution while keeping each cell in place, measuring both proteins and gene expression across 106 kidney biopsies and confirming the findings in an independent group of patients at Johns Hopkins.

Baker led the study with Lloyd Cantley, M.D., C. N. H. Long Professor of Medicine (Nephrology) and professor of cellular and molecular physiology at YSM, who is the study's senior author and has been her mentor throughout the project.

Cantley explains that this level of detail was central to the team's goal of identifying the immune pathways specific to AIN.

"As our kidneys clear medications from the blood, they can inadvertently modify the drug in a way that tricks the immune system into thinking it is a new antigen and responding by activating inflammatory cells that in turn damage the kidney tubules," says Cantley.

"By identifying those pathways that specifically trigger and amplify that kidney-specific immune activation, we can improve our treatment strategies to targeted blockade of only those that drive kidney damage," Cantley adds.

Immune clusters may sustain kidney inflammation

One important finding involved CXCL9, a signaling molecule produced in response to inflammation that draws T cells into tissue. In AIN, CXCL9 signaling was concentrated within organized clusters of immune cells called lymphoid aggregates. The T cells within these clusters appeared to signal primarily to one another, suggesting a feedback loop that may amplify and sustain inflammation.

This finding was largely specific to biopsies from patients with AIN, explains Baker. "Organized clusters of immune cells formed in nearly every AIN biopsy we examined, but in only a minority of biopsies from acute tubular injury, another common cause of AKI, and in none of the healthy kidneys," she says.

"These clusters appear to create a self-reinforcing loop, which could help explain why the inflammation sometimes continues even after the triggering medication or other inciting factor is removed," she adds. "It is like a little engine that keeps itself running, and we have to figure out how to turn it off."

Baker notes that the kidney's own cells are also active participants in the disease, with injured tubule cells producing signaling molecules that attract immune cells.

Toward treatments that target specific pathways

These findings may eventually help improve treatment for AIN, as current options remain limited, Baker says.

"Steroids are the primary treatment for AIN, but they are a very blunt instrument," she says. "They suppress inflammation broadly rather than targeting the specific pathways driving the condition, and they fail to restore kidney function in a substantial share of patients."

"Right now, we stop the triggering medication, give steroids and monitor kidney function," she adds. "But inflammation can continue to smolder even after treatment, and many patients are left with lasting kidney damage."

Several pathways identified in the study can also be blocked by drugs already approved for other diseases, potentially providing a practical path toward testing targeted treatments for AIN. Cantley says the findings provide a road map for the team's next phase of research.

"We are in the process of determining which of the pathways identified in this initial set of AIN biopsies are activated by specific classes of AIN-trigger medications, so that we can design clinical trials of targeted therapies optimized for the right patients," he says.

Publication details

Megan L. Baker et al., Spatial analysis reveals cellular microenvironments and mechanisms of inflammation and injury in acute interstitial nephritis, Nature Communications (2026). DOI: 10.1038/s41467-026-77210-y

Journal information: Nature Communications

Who's behind this story?

Swati Mestri

Swati Mestri

Swati Mestri holds a bachelor's degree in Electronics Engineering and has worked as a content editor since 2019. She has experience editing research documents across technology, health care, and materials science, and has a particular interest in technology and space. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Kidney biopsy maps reveal immune clusters that may keep inflammation going (2026, October 13) retrieved 13 October 2026 from https://medicalxpress.com/news/2026-10-kidney-biopsy-reveal-immune-clusters.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com